Andrew ElBardissi, M.D. Named to NeoChord Board of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
119
Andrew ElBardissi, M.D. Named to NeoChord Board of Directors

ST. LOUIS PARK, Minn., July 10, 2017 (GLOBE NEWSWIRE) -- NeoChord, Inc. , a privately-held medical technology company leading the advancement of minimally invasive valve repair for degenerative mitral regurgitation (DMR), today announced the appointment of Andrew ElBardissi, M.D. to its Board of Directors, effective immediately. Dr. ElBardissi is replacing Avi Kometz, MD as the representative from Deerfield Management on the NeoChord Board of Directors.    

“We are pleased to add Andrew to our Board of Directors, and we look forward to his strategic guidance. With his experience in early stage medical technology development, cardiothoracic surgery and research, Andrew will be of great benefit to the company as we continue progress with our US clinical trial,” said David Chung, President and Chief Executive Officer. “Avi has been an integral part of NeoChord over the past few years, and we are thankful for his partnership and many contributions.”

“I am delighted to join an organization leading the way in minimally invasive treatment of structural heart disease,” said Andrew ElBardissi, “I am looking forward to providing guidance as a member of the Board of Directors as the company continues to excel with their world class clinical, commercial and R&D programs."

Dr. ElBardissi has significant investment experience in the healthcare sector. He is currently an investor on the Private Transactions team at Deerfield Management Company and has previously held roles as an early stage life-sciences venture investor and investment banker.  He received residency training in General Surgery at Harvard Medical School’s Brigham and Women’s Hospital and in Cardiothoracic Surgery at Stanford University.  Dr. ElBardissi has been independently funded by the National Institutes of Health and the Agency for Healthcare Research and Quality, has over 30 publications in leading peer reviewed scientific journals and as presented his research at numerous medical and surgical conferences.    

About NeoChord, Inc. Founded in 2007 and based in St. Louis Park, Minnesota, NeoChord, Inc. is a privately held medical technology company leading the advancement of minimally invasive repair for DMR. NeoChord’s DS1000 system received CE market clearance in December 2012. NeoChord received IDE approval from the FDA for the US pivotal trial in May 2016. For more information, please visit the Company's website at  www.neochord.com .

The NeoChord DS1000 System is CE marked and approved for sale in Europe. 

CAUTION: Investigational Device Limited by Federal (United States) Law to Investigational Use.

NEOCHORD, DS1000, RECHORD, the stylized logos, and Transforming Mitral Valve Repair are registered trademarks or service marks of the NeoChord Corporation.

Contact: Bruce Van Deman NeoChord, Inc. (952) 698-7812 or (949) 413-1301 bvandeman@neochord.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MATIC S68 Wheels: A Bold Step for Superteam

Updated Category News Views 6

Premium Racing Takes a New Spin Scratch the surface of a tire-obsessed market, and you'll find Superteam Wheels making a calculated leap. Their new premium sub-brand, MATIC, isn't just fluff—it shows a serious attempt to impress those who’d rather cut corners on a track than a spreadsheet. Introducing the MATIC S68—buttery smooth, pitch-perfect, and undeniably...

Continue Reading
Supercar Buying: Key Factors to Verify First

Updated Category News Views 6

The Grind of Securing a Limited-Edition Supercar If you're grinding to buy one of those elusive limited-edition supercars, you'd better buckle up. According to Kendall Gath over at iLusso, this ain't like picking up groceries at the local market. There's a whole list of things to consider before you even think about handing over your wad of cash. Differentiating Fact from...

Continue Reading
ZPMC's Wind Power and Port Projects Earn Top Honors

Updated Category News Views 3

Wind Farms and Ports: A Winning Formula National applause rings out for Shanghai Zhenhua Heavy Industries Co., Ltd. (ZPMC) as they snagged top honors in the recent National Quality Engineering Awards. It's about time folks recognized the heavy lifting these projects do in reshaping our energy and port infrastructure. Two of their standout projects walked away with...

Continue Reading
Rural Hospitals Face Shaky Future; Warbird RCM Steps In

Updated Category News Views 6

Revamping Revenue Cycle Management for Rural Healthcare In a world that's increasingly teetering on the delicate tightrope of balance sheets, Warbird Healthcare Advisors is stepping into the ring with fists up, ready to fight for rural hospitals. Introducing their latest venture, Warbird RCM Partners, they're honing in on revenue cycle management and billing services to...

Continue Reading
Align™ Unveils Stylish Yet Sturdy Footwear for Fall

Updated Category News Views 2

New Season, New Style: Align™ Hits the Mark Align™ is rolling out its Fall-Winter 2026 men's footwear lineup, and if you're looking for styles that marry form with function, you're in for a treat. Launched just a year ago under the umbrella of H.H. Brown, Align's guns are blazing with a collection set to make some noise in the footwear world. Stepping Into Fall: Fresh...

Continue Reading
China's Sewing Machine Exports: Global Expansion Surge

Updated Category News Views 5

China's Position as a Sewing Machine Powerhouse It seems like the global sewing machine market is having a bit of a renaissance, and China's sitting pretty right at the center. You see, places like Taizhou in Zhejiang Province aren’t just pushing out volume—they're slamming market demand with innovation and precision. Once known primarily as the manufacturing hub,...

Continue Reading
Lincoln Educational Faces Investor Lawsuit Over Revenue Drop

Updated Category News Views 3

Investors Face Rough Waters Okay, let’s dive into this latest mess at Lincoln Educational Services Corp. (NASDAQ:LINC). Things aren't smelling too rosy over at their headquarters. If you've got shares here, you’ll know what I mean. Back in early May, the folks running Lincoln threw a garden party talking up a 19.5% growth in student starts. Who wouldn’t get behind...

Continue Reading
Concierge Hybrid Choice™: Transforming Patient Care

Updated Category News Views 1

A New Way to Nurture Patient Relationships This isn't just another cookie-cutter patient care program rolling out—it’s a genuine shake-up in the way doctors connect with their patients. Rishika Kaundal, MD, a dedicated family medicine physician, is pioneering change in Midlothian, Virginia with her Hybrid Choice™ concierge program. This isn't a fluff piece; it's a...

Continue Reading
Miraculous Medical Team Effort Saves Newborn's Life

Updated Category News Views 3

A Medical Feat: Teamwork at Its Pinnacle You want a story that restores your faith in humanity? Well, this one from Memorial Healthcare System and Joe DiMaggio Children's Hospital might just do the trick. The tale of baby Jay'ce, born with a neck mass threatening his breath, is straight out of a medical drama—albeit without the Hollywood scriptwriters' spin. It’s rare...

Continue Reading
Advocacy for Hiring Disabled Kidney Patients Gains Steam

Updated Category News Views 4

Making Jobs Accessible for Kidney Patients Well, things are stirring up on Capitol Hill, and it's high time, if you ask me. The American Association of Kidney Patients (AAKP) is rallying hard for a bipartisan bill that could change the landscape for folks grappling with kidney diseases and disabilities. You’ve got Reps Pete Sessions and Steny Hoyer pushing this American...

Continue Reading

Top 5 Most Recently Viewed Articles

Canadian National Railway's Upcoming Earnings: What to Expect

Updated Category News Views 50

Understanding the Anticipation Around Canadian National Railway's Earnings Canadian National Railway (NYSE: CNI) is poised to release its quarterly earnings report soon. Investors are eagerly watching for key indicators that may influence the stock's performance following the announcement. Analysts are forecasting an earnings per share (EPS) of $1.33, creating a buzz...

Continue Reading
Vow ASA Announces Successful Settlement of VGM Shares

Updated Category News Views 147

Vow ASA Successfully Concludes VGM Shares Settlement Vow ASA is delighted to share that it has successfully finalized the settlement for its shares held in Vow Green Metals AS (VGM). The convertible loan provided to VGM has also been completely repaid. This achievement marks a significant milestone for Vow ASA (ticker VOW) as it continues to strengthen its financial...

Continue Reading
Trinity Biotech Secures $4 Million for Growth and Innovation

Updated Category News Views 218

Trinity Biotech Secures $4 Million in Additional Funding Trinity Biotech plc (Nasdaq: TRIB), headquartered in Ireland, is a prominent biotechnology company dedicated to developing innovative solutions for human diagnostics and diabetes management. Recently, the company announced a substantial achievement in securing an additional $4 million in debt financing from its main...

Continue Reading
Middlefield Healthcare ETF Announces Quarterly Distributions for You

Updated Category News Views 158

Distribution Announcements for Middlefield Healthcare Dividend ETF TORONTO, a new announcement is here from Middlefield Healthcare Dividend ETF (TSX: MHCD) that promises to pique the interest of unitholders. The Fund is excited to share the details regarding its distributions for the last quarter of the year. Ensuring unitholders are well-informed about their investments...

Continue Reading
Zions Bancorporation Investors Invited to Join Securities Class Action

Updated Category News Views 175

Investigation into Zions Bancorporation's Securities Practices Recent developments have raised alarms for investors associated with Zions Bancorporation, N.A. (NASDAQ: ZION). The Rosen Law Firm, known for advocating investors' rights, is actively investigating claims that the institution may have misled the public concerning its financial practices. What Investors Need to...

Continue Reading